- Home
- ESEA vs CERS Comparison
ESEA vs CERS Comparison
Compare ESEA & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESEA
- CERS
- Stock Information
- Founded
- ESEA 2005
- CERS 1991
- Country
- ESEA Greece
- CERS United States
- Employees
- ESEA N/A
- CERS N/A
- Industry
- ESEA Marine Transportation
- CERS EDP Services
- Sector
- ESEA Consumer Discretionary
- CERS Technology
- Exchange
- ESEA Nasdaq
- CERS Nasdaq
- Market Cap
- ESEA 293.8M
- CERS 324.3M
- IPO Year
- ESEA 2006
- CERS 1997
- Fundamental
- Price
- ESEA $42.77
- CERS $1.72
- Analyst Decision
- ESEA Buy
- CERS Buy
- Analyst Count
- ESEA 1
- CERS 3
- Target Price
- ESEA $53.00
- CERS $3.17
- AVG Volume (30 Days)
- ESEA 35.7K
- CERS 2.0M
- Earning Date
- ESEA 11-20-2024
- CERS 10-30-2024
- Dividend Yield
- ESEA 5.61%
- CERS N/A
- EPS Growth
- ESEA 16.05
- CERS N/A
- EPS
- ESEA 16.98
- CERS N/A
- Revenue
- ESEA $205,168,137.00
- CERS $176,229,000.00
- Revenue This Year
- ESEA $13.42
- CERS $26.47
- Revenue Next Year
- ESEA $4.22
- CERS $11.48
- P/E Ratio
- ESEA $2.52
- CERS N/A
- Revenue Growth
- ESEA 14.96
- CERS 14.71
- 52 Week Low
- ESEA $26.20
- CERS $1.38
- 52 Week High
- ESEA $50.92
- CERS $2.59
- Technical
- Relative Strength Index (RSI)
- ESEA 53.34
- CERS 47.71
- Support Level
- ESEA $39.67
- CERS $1.59
- Resistance Level
- ESEA $41.91
- CERS $2.03
- Average True Range (ATR)
- ESEA 1.30
- CERS 0.14
- MACD
- ESEA 0.21
- CERS 0.02
- Stochastic Oscillator
- ESEA 93.09
- CERS 39.22
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.